Related references
Note: Only part of the references are listed.Functional implications of tetraspanin proteins in cancer biology
Pedro A. Lazo
CANCER SCIENCE (2007)
An investigation of two multivariate permutation methods for controlling the false discovery proportion
Edward L. Korn et al.
STATISTICS IN MEDICINE (2007)
The heat shock protein HSP70 promotes mouse NK cell activity against tumors that express inducible NKG2D ligands
Leslie Elsner et al.
JOURNAL OF IMMUNOLOGY (2007)
Confirmation of a BRAF mutation-associated gene expression signature in melanoma
Peter Johansson et al.
PIGMENT CELL RESEARCH (2007)
Development and applications of a BRAF oligonucleoticle microarray
Il-Jin Kim et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2007)
Syntenin-1 is a new component of tetraspanin-enriched microdomains: Mechanisms and consequences of the interaction of syntenin-1 with CD63
Nadya Latysheva et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
In melanoma, RAS mutations are accompanied by switching signaling from BRAF to CRAF and disrupted cyclic AMP signaling
Nicolas Dumaz et al.
CANCER RESEARCH (2006)
Differences in global gene expression in melanoma cell lines with and without homozygous deletion of the CDKN2A locus genes
Sandra Bloethner et al.
MELANOMA RESEARCH (2006)
Influence of melanoma inhibitory activity on transforming growth factor-beta signaling in malignant melanoma
Tanja Rothhammer et al.
MELANOMA RESEARCH (2006)
Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature
Keith S. Hoek et al.
PIGMENT CELL RESEARCH (2006)
Profiling of the tetraspanin web of human colon cancer cells
F Le Naour et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Gene expression profiling of primary cutaneous melanoma and clinical outcome
VR Winnepenninckx et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
The role of genetic markers-NAP1L1, MAGE-D2, and MTA1 -: in defining small-intestinal carcinoid neoplasia
M Kidd et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
Protein kinase activity is associated with CD63 in melanoma cells
J Iida et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2005)
Molecular classification of papillary thyroid carcinoma:: distinct BRAF, RAS, and RET/PTC mutation-specific gene expression profiles discovered by DNA microarray analysis
TJ Giordano et al.
ONCOGENE (2005)
BRAFE600-associated senescence-like cell cycle arrest of human naevi
C Michaloglou et al.
NATURE (2005)
Colocalization of the tetraspanins, CO-029 and CD151, with integrins in human pancreatic adenocarcinoma:: Impact on cell motility
S Gesierich et al.
CLINICAL CANCER RESEARCH (2005)
No evidence for BRAF as a melanoma/nevus susceptibility gene
S Jackson et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2005)
BRAF mutations are sufficient to promote nevi formation and cooperate with p53 in the genesis of melanoma
EE Patton et al.
CURRENT BIOLOGY (2005)
Incidence of BRAF oncogene mutation and clinical relevance for primary cutaneous melanomas
M Shinozaki et al.
CLINICAL CANCER RESEARCH (2004)
BRAF mutations are common somatic events in melanocytic nevi
R Kumar et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2004)
Microarray expression profiling in melanoma reveals a BRAF mutation signature
S Pavey et al.
ONCOGENE (2004)
Absence of exon 15 BRAF germline mutations in familial melanoma
J Lang et al.
HUMAN MUTATION (2003)
High frequency of BRAF mutations in nevi
PM Pollock et al.
NATURE GENETICS (2003)
Mutations of the BRAF gene in human cancer
H Davies et al.
NATURE (2002)
Share Paper
